— Know what they know.
Not Investment Advice

GWLL OTC

Goldenwell Biotech, Inc.
1W: +0.0% 1M: -1.5% 3M: +32.6% YTD: -76.2% 1Y: +244.8%
$0.69
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Sell · Power 38 · $68.3M mcap · 36M float · 0.0004% daily turnover · Short 65% of daily vol

Balance Sheet Trends

Total Assets
$224K -1.7% ▼
5Y CAGR: -1.9%
Total Liabilities
$271K +89.4% ▲
Shareholders Equity
-$47K -155.8% ▼
Cash & Investments
$49K -7.2% ▼
5Y CAGR: -27.5%
Total Debt
$96K +0.0% ▲
Net Debt
$46K +186.8% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$249K$214K$46K$53K$49K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$249K$214K$46K$53K$49K
Net Receivables$0$0$0$0$0
Inventory$0$0$0$0$0
Other Current Assets$0$0$0$0$0
Total Current Assets$249K$412K$222K$228K$224K
Property, Plant & Equip.$0$49K$26K$0$0
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$0$49K$26K$1$0
Total Assets$249K$461K$248K$228K$224K
— Liabilities —
Accounts Payable$0$111K$0$0$0
Short-Term Debt$0$0$0$0$0
Deferred Revenue$0$0$1K$1K$2K
Other Current Liabilities$0$0-$27K$1K$0
Total Current Liabilities$0$159K$27K$1K$2K
Long-Term Debt$0$0$0$0$96K
Other Non-Current Liab.$0-$2$20K$142K$174K
Total Non-Current Liabilities$0-$2$20K$142K$270K
Total Liabilities$0$159K$47K$143K$271K
— Equity —
Common Stock$9K$10K$10K$10K$10K
Retained Earnings-$9K-$126K-$1M-$1M-$1M
Accumulated OCI-$78K-$1$0$0$0
Total Stockholders Equity$249K$302K$202K$85K-$47K
Total Liabilities & Equity$249K$461K$248K$228K$224K
— Key Metrics —
Total Debt$0$48K$25K$0$96K
Net Debt-$249K-$166K-$21K-$53K$46K
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms